loader
Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 379,820Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 57ONYX PHARMS AMGEN

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Boulder Peptide 2024
Not Confirmed
arrow
Boulder Peptide 2024
Not Confirmed

CARFILZOMIB

US Patent Number : 7491704

Drug Substance Claim :

Drug Product Claim :

Application Number : 202714

Patent Use Code : U-1260

Delist Requested :

Patent Use Description : TREATMENT OF PATIENTS ...

Patent Expiration Date : 2025-04-14

blank

02

arrow
Boulder Peptide 2024
Not Confirmed
arrow
Boulder Peptide 2024
Not Confirmed

CARFILZOMIB

US Patent Number : 8207127

Drug Substance Claim :

Drug Product Claim :

Application Number : 202714

Patent Use Code : U-1260

Delist Requested :

Patent Use Description : TREATMENT OF PATIENTS ...

Patent Expiration Date : 2025-04-14

blank

03

arrow
Boulder Peptide 2024
Not Confirmed
arrow
Boulder Peptide 2024
Not Confirmed

CARFILZOMIB

US Patent Number : 7491704

Drug Substance Claim :

Drug Product Claim :

Application Number : 202714

Patent Use Code : U-2319

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-04-14

blank

04

arrow
Boulder Peptide 2024
Not Confirmed
arrow
Boulder Peptide 2024
Not Confirmed

CARFILZOMIB

US Patent Number : 8207127

Drug Substance Claim :

Drug Product Claim :

Application Number : 202714

Patent Use Code : U-2320

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-04-14

blank

05

arrow
Boulder Peptide 2024
Not Confirmed
arrow
Boulder Peptide 2024
Not Confirmed

CARFILZOMIB

US Patent Number : 8129346

Drug Substance Claim :

Drug Product Claim :

Application Number : 202714

Patent Use Code : U-2320

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-04-14

blank

06

arrow
Boulder Peptide 2024
Not Confirmed
arrow
Boulder Peptide 2024
Not Confirmed

CARFILZOMIB

US Patent Number : 8129346

Drug Substance Claim :

Drug Product Claim :

Application Number : 202714

Patent Use Code : U-2319

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-04-14

blank

07

arrow
Boulder Peptide 2024
Not Confirmed
arrow
Boulder Peptide 2024
Not Confirmed

CARFILZOMIB

US Patent Number : 8207127

Drug Substance Claim :

Drug Product Claim :

Application Number : 202714

Patent Use Code : U-1260

Delist Requested :

Patent Use Description : TREATMENT OF PATIENTS ...

Patent Expiration Date : 2025-04-14

blank

08

arrow
Boulder Peptide 2024
Not Confirmed
arrow
Boulder Peptide 2024
Not Confirmed

CARFILZOMIB

US Patent Number : 8129346

Drug Substance Claim :

Drug Product Claim :

Application Number : 202714

Patent Use Code : U-1260

Delist Requested :

Patent Use Description : TREATMENT OF PATIENTS ...

Patent Expiration Date : 2025-04-14

blank

09

arrow
Boulder Peptide 2024
Not Confirmed
arrow
Boulder Peptide 2024
Not Confirmed

CARFILZOMIB

US Patent Number : 8129346

Drug Substance Claim :

Drug Product Claim :

Application Number : 202714

Patent Use Code : U-1260

Delist Requested :

Patent Use Description : TREATMENT OF PATIENTS ...

Patent Expiration Date : 2025-04-14

blank

10

arrow
Boulder Peptide 2024
Not Confirmed
arrow
Boulder Peptide 2024
Not Confirmed

CARFILZOMIB

US Patent Number : 7491704

Drug Substance Claim :

Drug Product Claim :

Application Number : 202714

Patent Use Code : U-1260

Delist Requested :

Patent Use Description : TREATMENT OF PATIENTS ...

Patent Expiration Date : 2025-04-14

blank